ShotsMai-Britt talked about the P-I/II clinical trial data and study design of its lead candidate in metastatic melanoma in an e-poster presentation at AACR 2022She also spoke about IO Biotech’s unique platform with tumor defense mechanisms to kill cancer cellsThe interview gives a profound understanding of how IO Biotech is advancing to…
